Dr. Ilya Rachman has spent thousands of hours with patients since opening his Tarzana internal medicine clinic, Rachman Medical Group, eight years ago. Day in and day out, he has witnessed the perpetual cycle of rise and fall in the health of patients treated for cancer with the longstanding arsenal of chemotherapy and radiation. They may get better, but only for a while – and, too often, only to succumb to the disease when the cancer inevitably evolves. With that in mind, Rachman founded Immix Biopharma Inc. The L.A.-based startup has an ambitious goal: Cure cancer with drugs that are made faster and more efficiently, without the toxic side effects. On Aug. 6, Immix announced that its drug Imx-110 had successfully brought a dog named Jerry into remission from late-stage lymphoma. Read the full story in the August 20 issue of the San Fernando Valley Business Journal.